Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 581 entries
View as:

89Zr-atezolizumab PET Scan and Lobular Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04222426 Org: User:
Start: 12/18/19 End: 05/01/22 Due: 05/01/23

Eating Experience at the Comprehensive Cancer Center Wards - a Qualitative Study

Phase: N/A Priority: Normal
NCT ID: NCT05614323 Org: User:
Start: 11/16/22 End: 11/26/23 Due: 11/26/24

Monolithic Zirconia With CAD/CAM Titanium Abutments: A 5-year Prospective Case Series Study

Phase: N/A Priority: Normal
NCT ID: NCT06110611 Org: User:
Start: 10/01/24 End: 06/01/26 Due: 06/01/27

Augmented Reality for Orthognatic Surgery Patient Education

Phase: N/A Priority: Normal
NCT ID: NCT06140043 Org: User:
Start: 10/01/23 End: 10/01/24 Due: 10/01/25

Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT03026907 Org: User:
Start: 05/31/16 End: 12/31/19 Due: 12/31/20

A Trial on the Effects of Bronchoscopic Lung Volume Reduction in Severe Emphysema.

Phase: N/A Priority: Normal
NCT ID: NCT03474471 Org: User:
Start: 07/31/18 End: 04/20/23 Due: 04/20/24

Cerebral Blood Flow During Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02272985 Org: User:
Start: 04/30/15 End: 11/30/15 Due: 11/30/16

Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men

Phase: N/A Priority: Normal
NCT ID: NCT06200311 Org: User:
Start: 07/25/24 End: 07/25/29 Due: 07/25/30

Research Into the Quality of the Dying Phase

Phase: N/A Priority: Normal
NCT ID: NCT02822690 Org: User:
Start: 10/31/16 End: 06/30/19 Due: 06/30/20

Ventilator-associated Injury (VAI) in Chronic Home Mechanical Ventilation

Phase: N/A Priority: Normal
NCT ID: NCT04521426 Org: User:
Start: 10/01/20 End: 09/01/23 Due: 09/01/24

BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA

Phase: N/A Priority: Normal
NCT ID: NCT00321178 Org: User:
Start: 05/31/06 End: 02/28/09 Due: 02/28/10

Accuracy of Nexfin® and NIBP to Predict IBP

Phase: N/A Priority: Normal
NCT ID: NCT02038270 Org: User:
Start: 09/30/11 End: 03/31/12 Due: 03/31/13

Submandibular Gland Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04593589 Org: User:
Start: 05/10/22 End: 01/01/29 Due: 01/01/30

Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)

Phase: N/A Priority: Normal
NCT ID: NCT01549483 Org: User:
Start: 05/31/12 End: 06/30/13 Due: 06/30/14

Study of Lanreotide to Treat Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01616927 Org: User:
Start: 06/30/12 End: 12/31/17 Due: 12/31/18

TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects

Phase: N/A Priority: Normal
NCT ID: NCT02276430 Org: User:
Start: 07/31/14 End: 04/30/25 Due: 04/30/26

Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate

Phase: N/A Priority: Normal
NCT ID: NCT03134846 Org: User:
Start: 12/16/17 End: 06/30/22 Due: 06/30/23

POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04193956 Org: User:
Start: 08/01/18 End: 09/30/24 Due: 09/30/25

Virtual Reality Training for Aggression Control

Phase: N/A Priority: Normal
NCT ID: NCT06047587 Org: User:
Start: 04/18/23 End: 04/18/25 Due: 04/18/26

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Phase: N/A Priority: Normal
NCT ID: NCT06374043 Org: User:
Start: 05/11/21 End: 09/13/22 Due: 09/13/23

Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study

Phase: N/A Priority: Normal
NCT ID: NCT04359459 Org: User:
Start: 11/01/22 End: 11/01/22 Due: 11/01/23

DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03485456 Org: User:
Start: 05/29/19 End: 01/01/22 Due: 01/01/23

Inflammation in Tinnitus

Phase: N/A Priority: Normal
NCT ID: NCT05268770 Org: User:
Start: 03/31/22 End: 08/31/22 Due: 08/31/23

AR and ER Imaging in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01988324 Org: User:
Start: 08/31/14 End: 09/30/15 Due: 09/30/16

TransplantLines: the Transplantation Biobank

Phase: N/A Priority: Normal
NCT ID: NCT03272841 Org: User:
Start: 06/30/15 End: 01/31/21 Due: 01/31/22